Tonsillectomy and Immunosuppression in Caucasian Patients With High-risk IgA-nephropathy

Recruiting now · Not applicable

Conditions studied: Primary IgA-nephropathy, High-risk, Caucasians

In brief

The open-label prospective non-randomised controlled aims to assess the efficacy of the combination of immunosupression (IST) and tonsillectomy (TE) in Caucasian patients at high risk of the IgA-nephropathy.

Key facts

Study ID
NCT07074951
Run by
St. Petersburg State Pavlov Medical University
People needed
240
Starts
2013-03-10
Expected to finish
2027-12-10
Last updated by the study team
2025-07-20

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.